Co-Authors
This is a "connection" page, showing publications co-authored by AMOL JITENDRA GHIA and TINA MARIE BRIERE.
Connection Strength
1.904
-
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol. 2023 Sep; 164(2):377-386.
Score: 0.239
-
Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases. Radiat Oncol J. 2023 Mar; 41(1):12-22.
Score: 0.232
-
Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol. 2023 Jan-Feb; 13(1):e7-e13.
Score: 0.226
-
Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously irradiated metastatic epidural spinal cord compression. N Am Spine Soc J. 2021 Jun; 6:100066.
Score: 0.204
-
Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. Radiother Oncol. 2020 11; 152:49-55.
Score: 0.193
-
Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol. 2020 Jun; 148(2):327-334.
Score: 0.190
-
Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience. J Neurosurg Spine. 2020 Feb 14; 1-9.
Score: 0.187
-
Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up. Radiother Oncol. 2019 09; 138:80-85.
Score: 0.179
-
Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk. Radiother Oncol. 2024 Apr; 193:110119.
Score: 0.062
-
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial. J Immunother Cancer. 2023 07; 11(7).
Score: 0.059
-
Comparison of setup accuracy and efficiency between the Klarity system and BodyFIX system for spine stereotactic body radiation therapy. J Appl Clin Med Phys. 2022 Nov; 23(11):e13804.
Score: 0.056
-
IMRT planning parameter optimization for spine stereotactic radiosurgery. Med Dosim. 2019 Winter; 44(4):303-308.
Score: 0.043
-
Prospective evaluation of target and spinal cord motion and dosimetric changes with respiration in spinal stereotactic body radiation therapy utilizing 4-D CT. J Radiosurg SBRT. 2016; 4(3):191-201.
Score: 0.035